Send Inquiry

Request To Call Back

Coronary Stent - Everolimus

Price 198.75 USD ($)/ Piece

Get a Price/Quote

MOQ : 1 Piece

Coronary Stent - Everolimus Specification

Shelf Life
3 Years

Measurement Range
2.25 mm to 4.0 mm diameter, 8 mm to 40 mm length

Usage Type
Single Use Only

Instruments Type
Interventional Cardiology

Storage Instructions
Store in cool, dry place, away from direct sunlight

Function
Restores blood flow, Prevents restenosis

Features
Thinnest strut design, High flexibility, Enhanced deliverability, Biocompatible polymer coating, Controlled drug release

Equipment Type
Coronary Stent

Material
Cobalt Chromium Alloy

Condition
New

Technology
Drug-Eluting Stent (DES) with Everolimus

Portable
Yes

Wall Mounted
No

Real-Time Operation
Yes

Operating Type
Interventional

Use
Coronary Artery Disease Treatment

Dimension (L*W*H)
Varies by model; typically 8-40 mm length, 2.25-4.0 mm diameter

Weight
< 1 g

Color
Metallic

Release Kinetics
Sustained release up to 3 months

Radial Strength
High

ISO Certification
ISO 13485:2016

Catheter Compatibility
Compatible with 5F, 6F delivery systems

Radiopacity
Excellent, facilitates positioning

Strut Thickness
60 microns

Drug Coating
Everolimus

Packaging
Individually packed in sterile blister

Sterilization Method
Ethylene Oxide

Crossability
Superior for complex lesions

About Coronary Stent - Everolimus

Cardiovascular Stent Coronary Stent

Minimal Balloon Overhang which minimizes the risk of edge dissection
A high radial strength which makes it ideal for proximal lesion
Low recoil ensures predictable results
Low deflation time
Excellent & uniform scaffolding
No Foreshortening suitable for Ostial lesion

Key Features

8 crowns for uniform & optimum vessel scaffolding
Customized crown length for 2.25, 2.50, 2.75, 3.0, 3.5, & 4.0 mm
Maintain consistent metal-artery ratio
Superior stent strength through strong cobalt chromium alloy
Thin Strut
Thin drug/polymer coating thickness: 4-5 micron
Excellent deliverability & conformability
Growth of 8 % from nominal pressure to RBP allowing complete deployment and good wall apposition
Available in length up to 48 mm

Advanced Drug-Eluting Technology

This coronary stent utilizes a sustained-release Everolimus coating, releasing the antiproliferative drug gradually over three months for optimal efficacy. The controlled drug delivery system is designed to significantly lower the risk of arterial restenosis, supporting long-term vessel patency and patient outcomes.

Patient-Centric Design and Flexibility

With a strut thickness of just 60 microns and high radial strength, the stent combines strength with flexibility. Its thin, cobalt-chromium design minimizes vascular injury while improving crossability, making it ideal for navigating complex coronary lesions. These attributes support quicker and more reliable procedures.

Safety, Compliance, and Easy Handling

ISO 13485:2016 certification assures compliance with international quality standards. Ethylene oxide sterilization provides assured sterility. The device is single-use, available in a range of sizes, and conveniently compatible with 5F or 6F delivery systems, streamlining the interventional process for clinicians.

FAQs of Coronary Stent - Everolimus:

Q: How does the Everolimus coating benefit patients with coronary artery disease?

A: The Everolimus drug coating delivers a controlled, sustained release of medication for up to three months. This helps inhibit excessive cell growth, effectively reducing the risk of restenosisensuring open arteries and improved long-term outcomes for patients.

Q: What makes this coronary stent suitable for complex lesions?

A: Its superior crossability, high radial strength, and ultra-thin 60-micron strut design allow the stent to navigate challenging and tortuous vessels, making it particularly effective for complex coronary lesions that require precise placement and flexibility.

Q: When should this stent be used during a cardiac procedure?

A: The stent is intended for use during interventional cardiology procedures to treat narrowed or blocked coronary arteries, particularly in patients at risk of restenosis or those with complex coronary lesions. It should be used as directed by a trained cardiologist.

Q: Where is the stent manufactured and supplied from?

A: This coronary stent is manufactured, exported, supplied, and traded in India, adhering to international standards such as ISO 13485:2016 to ensure consistent quality and safety.

Q: What is the process for storing and handling this stent before use?

A: Each stent is individually packed in a sterile blister and should be stored in a cool, dry environment away from direct sunlight. Proper storage ensures preservation of its sterility and effectiveness until used.

Q: How does the stents compatibility with catheter systems benefit clinical procedures?

A: Compatibility with both 5F and 6F delivery systems provides flexibility for the interventional team and facilitates smooth positioning and implantation during various cardiac procedures.

Tell us about your requirement